Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
cancer
9
×
national blog main
texas blog main
9
×
texas top stories
national top stories
biotech
boston blog main
life sciences
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
wisconsin blog main
wisconsin top stories
medical devices
startups
clinical trials
fda
novartis
bristol-myers squibb
cancer immunotherapy
drugs
innovation
investing
ipo
merck
What
new
9
×
roundup
bio
drug
life
announced
center
companies
fda
innovation
ipo
latest
medical
news
plan
science
sciences
texas
action
activity
advantages
antonio
approval
approvals
approved
bails
bar
biobridge
biogen
biogen’s
biopharmaceutical
biotechs
brand
bridgebio
bringing
brings
businesses
cancer
capital
car
Language
unset
Current search:
new
×
cancer
×
" texas blog main "
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
JLabs’ Luby Takes the Reins at TMC Innovation Institute in Houston
@xconomy.com
5 years ago
San Antonio Develops “Action Plan” to Draw Life Sciences Businesses
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@xconomy.com
5 years ago
TX Roundup: TMC’s BioBridge to the UK, New Execs at Fannin & TechFW
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M